Peer-reviewed veterinary case report
ESBL E. coli found in bile of two UK dogs with liver infection
By Timofte, Dorina et al.·Published in Journal of clinical microbiology·2011·University of Liverpool, United Kingdom·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Detection of extended-spectrum-beta-lactamase-positive Escherichia coli in bile isolates from two dogs with bacterial cholangiohepatitis.
- Species:
- dog
Plain-English summary
A dog in the UK was diagnosed with bacterial cholangiohepatitis, which is an infection affecting the liver and bile ducts. Tests revealed that the bacteria causing the infection were a type of E. coli that is resistant to many antibiotics, known as extended-spectrum beta-lactamase (ESBL)-positive E. coli. This is concerning because it can make treatment more complicated. The dog likely received specific antibiotics that are effective against this resistant strain, but the details on the outcome are not provided.
People also search for: dog liver infection treatment · antibiotic-resistant E. coli in dogs · cholangiohepatitis in dogs
Abstract
This is the first report of Escherichia coli isolates producing CTX-M-15, the predominant type of extended-spectrum β-lactamase (ESBL) associated with clinical disease in humans in the United Kingdom, in a United Kingdom pet dog. This report also describes the first isolation of CTX-M/Tem ESBL-positive E. coli from bile in dogs with hepatobiliary disease.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/21775537/